Good at minimally invasive targeted treatment technology based on local tumor cell inactivation. All treatments are targeted at tumor cells, not normal cells, so the treatment is more effective and has fewer toxic and side effects. It is highly targeted, less traumatic, does not increase pain, and does not damage immune function. Especially for mid- and late-stage tumors, it can greatly increase the cure rate and improve the quality of life of patients. It avoids the disadvantages of traditional treatments, such as high destructiveness, high toxic and side effects, high pain, low treatment efficiency, and incomplete efficacy.

Member of the First International Medical Exchange Branch of the Chinese Anti-Cancer Association.